Packages of top drug brands to have QR codes from today

Posted on:
Key Points

India's top 300 brands of drugs including widely-used analgesics, pain relievers, anti-platelet, vitamin supplements, blood-sugar lowering medicines and contraceptive tablets will have to put QR codes on their packages from August 1..

The National Pharmaceuticals Pricing Authority (NPPA) had last year identified brands including Dolo, Saridon Fabiflu, Ecosprin, Limcee, Sumo, Calpol, Corex syrup, Unwanted 72 and Thyronorm..

The stored data or information would include the unique product identification code, the name of the API, brand name (if any), name and address of the manufacturer, batch number, batch size, date of manufacture, date of expiry or retesting, serial shipping container code, manufacturing licence number or import licence number and the special storage conditions required...

You might be interested in

Rs 5 lakh per visit & a secret code: How Pak national sailed to India with a mothership full of drugs

26, May, 23

A May 13 operation by NCB and the Navy led to the seizure of 2,525 kg of 'high-purity meth' and the arrest of a 29-year-old suspected to be a part of the infamous Haji Salim drug cartel

India committed to delivering top-quality drugs: Union Health Minister Mansukh Mandaviya

21, Aug, 23

India is dedicated to providing affordable, high-quality drugs and contribute to global accessibility to quality medicines, Union Health Minister Mansukh Mandaviya said on Sunday even as his counterpart from The Netherlands hailed Indian drugs as life-saving close on the heels of some red flags over

Govt plans common drugs standards for all state regulators

16, Mar, 23

The move could instil order and unify a fragmented system spanning 38 drug regulators, each with its own database | Latest News India

Global pharma majors pitch for faster approval of innovative drugs in India but CDSCO remains cautious

01, Jan, 24

Organisation of Pharmaceutical Producers of India seeks nod for drugs to be marketed at same time as US, Europe. But regulator rarely permits a drug launch without local clinical trials.

Safety concerns over e-pharma put Centre in a spot

29, Apr, 23

While there are talks about a complete ban on e-pharmacy, earlier this year the DCGI sent show-cause notices to 20-odd e-pharmacies.

India’s luxury vehicle market will hit record high by yearend: Lexus India president

08, Aug, 23

India Business News: CHENNAI: India’s luxury vehicle market will hit a record high of 42,000-45,000 units by the end of calendar year 2023, higher than the last peak of 41.

'Adulterated drugs’ to breakthrough cancer therapy — how India's health & pharma sector fared in 2023

08, Dec, 23

The year was eventful with National Medical Commission's flip-flops over controversial decisions, tightening of various norms and launch of made-in-India drugs to treat rare diseases.